Chen, C. I., Kouroukis, C. T., White, D., Voralia, M., Stadtmauer, E., Stewart, A. K., Wright, J. J., Powers, J., Walsh, W., & Eisenhauer, E. (2007). Bortezomib is active in patients with untreated or relapsed Waldenström's macroglobulinemia: A phase II study of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology, 25(12), 1570-1575. https://doi.org/10.1200/JCO.2006.07.8659
Bortezomib is active in patients with untreated or relapsed Waldenström's macroglobulinemia: A phase II study of the National Cancer Institute of Canada Clinical Trials Group. / Chen, Christine I.; Kouroukis, C. Tom
; White, Darrell et al.
In:
Journal of Clinical Oncology, Vol. 25, No. 12, 20.04.2007, p. 1570-1575.
Research output: Contribution to journal › Article › peer-review
Chen, CI, Kouroukis, CT, White, D, Voralia, M, Stadtmauer, E, Stewart, AK, Wright, JJ, Powers, J, Walsh, W & Eisenhauer, E 2007, 'Bortezomib is active in patients with untreated or relapsed Waldenström's macroglobulinemia: A phase II study of the National Cancer Institute of Canada Clinical Trials Group', Journal of Clinical Oncology, vol. 25, no. 12, pp. 1570-1575. https://doi.org/10.1200/JCO.2006.07.8659
Chen CI, Kouroukis CT, White D, Voralia M, Stadtmauer E, Stewart AK et al. Bortezomib is active in patients with untreated or relapsed Waldenström's macroglobulinemia: A phase II study of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology. 2007 Apr 20;25(12):1570-1575. doi: 10.1200/JCO.2006.07.8659
Chen, Christine I. ; Kouroukis, C. Tom ; White, Darrell et al. / Bortezomib is active in patients with untreated or relapsed Waldenström's macroglobulinemia : A phase II study of the National Cancer Institute of Canada Clinical Trials Group. In: Journal of Clinical Oncology. 2007 ; Vol. 25, No. 12. pp. 1570-1575.
@article{93bbb8cbe8ca48c9bb17c53f705bd826,
title = "Bortezomib is active in patients with untreated or relapsed Waldenstr{\"o}m's macroglobulinemia: A phase II study of the National Cancer Institute of Canada Clinical Trials Group",
author = "Chen, {Christine I.} and Kouroukis, {C. Tom} and Darrell White and Michael Voralia and Edward Stadtmauer and Stewart, {A. Keith} and Wright, {John J.} and Jean Powers and Wendy Walsh and Elizabeth Eisenhauer",
year = "2007",
month = apr,
day = "20",
doi = "10.1200/JCO.2006.07.8659",
language = "English",
volume = "25",
pages = "1570--1575",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "12",
}
TY - JOUR
T1 - Bortezomib is active in patients with untreated or relapsed Waldenström's macroglobulinemia
T2 - A phase II study of the National Cancer Institute of Canada Clinical Trials Group
AU - Chen, Christine I.
AU - Kouroukis, C. Tom
AU - White, Darrell
AU - Voralia, Michael
AU - Stadtmauer, Edward
AU - Stewart, A. Keith
AU - Wright, John J.
AU - Powers, Jean
AU - Walsh, Wendy
AU - Eisenhauer, Elizabeth
PY - 2007/4/20
Y1 - 2007/4/20
UR - http://www.scopus.com/inward/record.url?scp=34248159391&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34248159391&partnerID=8YFLogxK
U2 - 10.1200/JCO.2006.07.8659
DO - 10.1200/JCO.2006.07.8659
M3 - Article
C2 - 17353550
AN - SCOPUS:34248159391
SN - 0732-183X
VL - 25
SP - 1570
EP - 1575
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 12
ER -